Central Texas Neurology Consultants, PA

Round Rock, Texas 78681

1 studies enrolling now · 9 studies all time

What they study most

Alzheimer's Disease, Excessive Daytime Sleepiness, Idiopathic Hypersomnia, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Myasthenia Gravis, OSA

Studies at this site

• A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2) — Recruiting now
• A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia — Completed
• Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) — Completed
• A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) — Running, not enrolling
• Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy — Completed
• A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia — Completed
• A Study of TAK-079 in People With Generalized Myasthenia Gravis — Completed
• Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS — Completed
• A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis — Completed